Bioatla Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
BCAB Nasdaq 8731 https://www.bioatla.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bioatla Inc

We Think BioAtla (NASDAQ:BCAB) Needs To Drive Business Growth Carefully - Mar 28th, 2024 11:02 am
BioAtla, Inc. (NASDAQ:BCAB) Q4 2023 Earnings Call Transcript - Mar 27th, 2024 2:07 pm
Q4 2023 Bioatla Inc Earnings Call - Mar 27th, 2024 11:56 am
BioAtla Inc (BCAB) Posts Q4 and Full Year 2023 Financial Results - Mar 26th, 2024 9:33 pm
BioAtla Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress - Mar 26th, 2024 8:01 pm
BioAtla to Announce Fourth Quarter and Full-Year 2023 Financial Results and Provide Business Highlights on March 26, 2024 - Mar 19th, 2024 12:00 pm
BioAtla Announces Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting - Mar 7th, 2024 1:00 pm
Co-Founder of BioAtla Jay Short Buys 2.3% More Shares - Dec 23rd, 2023 1:13 pm
BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference - Dec 20th, 2023 1:00 pm
After losing 78% in the past year, BioAtla, Inc. (NASDAQ:BCAB) institutional owners must be relieved by the recent gain - Dec 15th, 2023 10:58 am
BioAtla Hosting Virtual R&D Day to Highlight BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types - Dec 13th, 2023 1:00 pm
BioAtla to Host Virtual R&D Day to Review BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types on Wednesday, December 13, 2023 - Dec 6th, 2023 1:00 pm
BioAtla Presented Phase 2 Clinical Trial Data at the IASLC 2023 North America Conference on Lung Cancer and Virtual KOL Event - Dec 5th, 2023 1:00 pm
BioAtla to Participate in the JMP Securities Hematology and Oncology Summit - Nov 30th, 2023 1:00 pm
BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC - Nov 28th, 2023 1:00 pm
BioAtla, Inc. (NASDAQ:BCAB) Q3 2023 Earnings Call Transcript - Nov 12th, 2023 2:24 pm
BioAtla Reports Third Quarter 2023 Financial Results and Highlights Recent Progress - Nov 7th, 2023 9:01 pm
BioAtla to Participate in the Jefferies London Healthcare Conference - Nov 6th, 2023 9:05 pm
We're Keeping An Eye On BioAtla's (NASDAQ:BCAB) Cash Burn Rate - Oct 20th, 2023 10:08 am
BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award - Oct 12th, 2023 11:30 am